Activity Code: 08MCG55A-DE03

Recertification Release Date: June 1, 2007
Expiration Date: June 31, 2008

Original Release Date: August 1, 2004
Original Expiration Date: July 31, 2004

TO RECEIVE CE CREDIT YOU SHOULD:

• Review each of the 3 articles in its entirety.
• Complete the post-test with a 70% or better.
• Complete the activity evaluation.

Estimated time to complete this activity as designed is 3 hours. Upon successful completion of these requirements, you will have online access to a printable credit statement.

If you have any questions about this process, please email the Center for Continuing and Outreach Education at ccoereg@umdnj.edu or the CCOE Enrollment Services at (800) 227-4852.

SPONSOR

Sponsored by the New Jersey Preparedness Training Consortium (NJ-PTC) and the University of Medicine & Dentistry of New Jersey (UMDNJ), School of Public Health.

Target Audience

This activity is designed for physicians, nurses, and other health care professionals in New Jersey who are involved in the care of persons with Public Health Emergencies.

Statement of Need

A variety of networks and collaborations have been initiated to develop training courses and improve public health, laboratory, and health care infrastructure after September 11th. However numerous needs assessments indicate that most health care professionals surveyed in NJ feel unprepared to meet their patients care needs and are unaware of what and to whom to report if a threat occurs, nor do they feel integrated into a response team network. There is a high perceived need in the following areas: Chemical, Radiological and Nuclear.

METHOD OF INSTRUCTION

Participants should read the learning objectives and review the activity in its entirety. After reviewing the material, complete the self-assessment test consisting of a series of multiple-choice and True/ False questions.

Upon completing this activity as designed and achieving a passing score of 70% or more on the self-assessment test, participants will receive a printable credit letter. Estimated time to complete this activity as designed is 3 hours.

Accreditation

PHYSICIANS:
UMDNJ–Center for Continuing and Outreach Education is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. UMDNJ–Center for Continuing and Outreach Education designates this educational activity for a maximum of 3.0 AMA PRA Category 1 credit(s)™. Physician should claim credit commensurate with the extent of their participation.

NURSES:
The University of Medicine and Dentistry of New Jersey-Continuing Education and Outreach Education is an approved provider of continuing nursing education by the New Jersey State Nurses Association, Provider Number P173-10/06-09. New Jersey State Nurses Association is accredited by the American Nurses Credentialing Center's Commission on Accreditation. This activity is awarded 3 contact hours.

UMDNJ-Center for Continuing and Outreach Education is an approved provider of continuing education by the California Board of Registered Nursing, Provider Number CEP 13780 for a maximum of 3 contact hours for this activity.

CEUs:
UMDNJ-Center for Continuing and Outreach Education certifies that this program meets the criteria for up to 0.3 Continuing Education Units (CEUs), provided the activity is completed as designed. One CEU equals 10 contact hours of participation in an organized continuing education experience under responsible sponsorship, capable direction and qualified instruction.

Faculty

STEVE M. MARCUS, MD is executive and medical director of NJPIES, the regionally designated poison and drug information program for the state of New Jersey. He is a professor of preventive medicine and community Health at New Jersey Medical School.

BRUCE RUCK, PHARMD is director of drug information and professional education of NJPIES and is on the faculty of the Rutgers College of Pharmacy.

JULIE K. TIMINS, MD is a diagnostic radiologist practicing in Jersey City and Morristown, New Jersey. She is a past president of the radiological Society of New Jersey and member of the New Jersey Commission on Radiation Protection.

JILL A. LIPOTI, PHD is the assistant director of Radiation Protection of the New Jersey Department of Environmental Protection and the commissioner’s designee to the New Jersey Commission on Radiation Protection. She sits on the Board of Trustees of the National Council on Radiation Protection and Measurements.

LAURA H, KAHN, MD, MPH, an internist, is a research staff member in the Program on Science and Clobal security in the Woodrow Wilson School of Public and International Affairs at Princeton University.

FRANK VON HIPPEL, PHD, a physicist, is a professor of public and international affairs at Princeton University. He organized the American Physical Society’s Study Group on Lightwater Reactor Safety, which first recommended (in 1975) to the Nuclear Regulatory Commission the use of KI to mitigate the consequences of reactor accidents.

Disclosure

In accordance with the disclosure policies of UMDNJ and to conform with ACCME and FDA guidelines, all program faculty are required to disclose to the activity participants: the existence of any financial interest or other relationships with the manufacturers of any commercial products/devices, or providers of commercial services, that relate to the content of their presentation/material, or the commercial contributors of this activity, that could be perceived as a real or apparent conflict of interest; and the identifi cation of a commercial product/device that is unlabeled for use or an investigational use of a product/device not yet approved.

Disclosure Declaration

The following have no financial relationships to disclose: Steve M. Marcus, MD; Bruce Ruck, PharmD; Julie K Timins, MD; Jill A. Lipoti, PhD; Laura H. Kahn, MD, MPH; and Frank von Hippel, PhD

Off-Label Usage Disclaimer

This activity does not contain information of commercial products/devices that are unlabeled for use or investigational uses of products not yet approved.

Disclaimer

The views expressed in this activity are those of the faculty. It should not be inferred or assumed that they are expressing the views of NJ-PTC, NJDHHS, UMDNJ, or any manufacturer of pharmaceuticals.

It should be noted that the recommendations made herein with regard to the use of therapeutic agents, varying disease states, and assessments of risk, are based upon a combination of clinical trials, current guidelines, and the clinical practice experience of the participating presenters. The drug selection and dosage information presented in this activity are believed to be accurate. However, participants are urged to consult the full prescribing information on any agent(s) presented in this activity for recommended dosage, indications, contraindications, warnings, precautions, and adverse effects before prescribing any medication.

Please direct CME related questions to UMDNJ at 973-972-4267 or email ccoereg@umdnj.edu. To review UMDNJ's privacy policy, click here.